Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer

Stopped early

Conditions studied: Endometrial Cancer

In brief

The purpose of this study is to evaluate the ability of PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging) to give physicians preoperative information about specific sites in the body that the endometrial cancer may be present. If the PET/MRI is accurate and successful in providing this information, then women in the future may be able to have less extensive surgery for their endometrial cancer after evaluation with PET/MRI.

Key facts

Study ID

NCT02765698

Run by

Mayo Clinic

People needed

2

Starts

2016-05-01

Expected to finish

2018-03-01

Last updated by the study team

2018-03-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Biopsy-proven high-risk endometrial cancer (type 2 or grade 3 endometrioid histology)
• BMI of at least 18.5 kg/m2 and less than 35 kg/m2 or axial diameter less than 25 cm
• Patients who pass standard clinical MRI screening procedures
• Receiving preoperative clinical evaluation at Mayo Clinic, Rochester, MN
• Undergoing surgical staging and/or debulking at Mayo Clinic in Rochester, MN

You may not qualify if…

• Allergy to FDG or gadolinium
• Contraindication to MRI scanning (Extreme claustrophobia preventing PET/MRI completion, patients who are unable to lay quietly for an additional 60 minutes of imaging
• Known kidney disease or poor renal function
• Pregnant

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.